Showing 111-120 of 340 results for "".
Discontinuing Disease-Modifying Therapy in Multiple Sclerosis: Should You Have an Exit Strategy?
https://practicalneurology.com/diseases-diagnoses/ms-immune-disorders/discontinuing-disease-modifying-therapy-in-multiple-sclerosis-should-you-have-an-exit-strategy/30303/Two experts sound off on the implications of indefinite treatment and whether DMTs should be stopped.Raising Urate With Inosine to Potentially Slow Progression of Parkinson's Disease
https://practicalneurology.com/diseases-diagnoses/movement-disorders/movement-disorders-focus/30688/Results of the Phase II SURE-PD study show inosine is safe and tolerable and raises urate levels, which have been inversely related to Parkinson's progression. Still, patients are cautioned against self-medicating before the next phase of this research effort is completed.A Comprehensive Approach to Managing Dementia Patients: Considering the Caregivers
https://practicalneurology.com/diseases-diagnoses/alzheimer-disease-dementias/a-comprehensive-approach-to-managing-dementia-patients-considering-the-caregivers/30777/A Q&A with Richard Isaacson, MDDementia Insights: Brain Health Navigators---Optimizing the Alzheimer Disease Care Pathway Through Boundary-Spanning Roles
https://practicalneurology.com/diseases-diagnoses/alzheimer-disease-dementias/brain-health-navigators-optimizing-the-alzheimer-disease-care-pathway-through-boundary-spanning-roles/56387/A collaborative care model addresses fragmented diagnostic pathways and prepares health care systems for emerging Alzheimer disease innovations and therapies.Primer on Botulinum Toxin Billing and Coding: What Neurologists Need to Know For 2014
https://practicalneurology.com/columns/practice-management/primer-on-botulinum-toxin-billing-and-coding-what-neurologists-need-to-know-for-2014/30679/Here's an update on strategies for earning appropriate reimbursement.King v. Burwell and the Future of the PPACA
https://practicalneurology.com/columns/practice-management/king-v-burwell-and-the-future-of-the-ppaca/30563/A decision by the US Supreme Court on tax credit eligibility could have an impact on the viability of public health care exchanges.- Dementia Insightshttps://practicalneurology.com/diseases-diagnoses/alzheimer-disease-dementias/pn-0707-dementia-pdf/31141/In the realm of dementia care, accurate CPT (Current Procedural Terminology) coding is crucial for appropriate reimbursement and reflecting the complexity of patient management. David S. Geldmacher, MD, addresses the challenges neurologists face when utilizing CPT codes for dementia evaluations in h
The MS Treatment Landscape: MSAA's 2014 MS Research Update Provides Vital Information to Medical Professionals, Members of the MS Community
https://practicalneurology.com/diseases-diagnoses/ms-immune-disorders/the-ms-treatment-landscape-msaas-2014-emms-research-updateem-provides-vital-information-to-medical-professionals-members-of-the-ms-community/30677/New publication compiles the latest developments in MS research.Physical Therapy for Low-Back Pain: How the Neurologist Can Facilitate Optimal Care
https://practicalneurology.com/diseases-diagnoses/headache-pain/PN0609_07-php/30911/Despite the frequency with which they order it, neurologists typically don't have formal training on the specifics of physical therapy. Here's how to make good referrals.The Influence of Family Health History on the Diagnosis of hATTR Amyloidosis
https://practicalneurology.com/diseases-diagnoses/headache-pain/the-influence-of-family-health-history-on-the-diagnosis-of-hattr-amyloidosis/30094/Bernice Bennett, genealogist, health education specialist, and co-founder and faculty member of the Midwest African American Genealogy Institute, discusses the Family Health History Road Trip, which emphasizes the important role family health history can play in driving earlier diagnosis of hATTR am